Compare TXT & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TXT | PODD |
|---|---|---|
| Founded | 1923 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.5B | 17.0B |
| IPO Year | 1994 | 2007 |
| Metric | TXT | PODD |
|---|---|---|
| Price | $96.54 | $240.88 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 20 |
| Target Price | $97.45 | ★ $358.00 |
| AVG Volume (30 Days) | ★ 1.6M | 1.0M |
| Earning Date | 04-29-2026 | 05-20-2026 |
| Dividend Yield | ★ 0.08% | N/A |
| EPS Growth | ★ 18.01 | N/A |
| EPS | ★ 5.11 | 3.48 |
| Revenue | ★ $14,799,000,000.00 | $2,708,100,000.00 |
| Revenue This Year | $5.78 | $24.33 |
| Revenue Next Year | $4.59 | $19.33 |
| P/E Ratio | ★ $19.45 | $70.10 |
| Revenue Growth | 8.01 | ★ 30.73 |
| 52 Week Low | $57.70 | $230.08 |
| 52 Week High | $101.57 | $354.88 |
| Indicator | TXT | PODD |
|---|---|---|
| Relative Strength Index (RSI) | 49.67 | 39.44 |
| Support Level | $95.67 | $238.68 |
| Resistance Level | $96.98 | $299.75 |
| Average True Range (ATR) | 2.60 | 8.49 |
| MACD | -0.36 | 0.86 |
| Stochastic Oscillator | 14.59 | 13.33 |
Textron is a conglomerate that designs, manufactures, and services a range of specialty aircraft including small jets, propeller-driven airplanes, helicopters, and tilt-rotor aircraft. Textron Aviation manufactures and services Cessna and Beechcraft planes. Bell is a helicopter and tilt-rotor manufacturer and servicer for both commercial and military customers. Textron Systems produces uncrewed aircraft and armored vehicles for the military market as well as aircraft simulators and training for the commercial and military markets. Textron Industrial contains the Kautex business, which manufactures plastic fuel tanks for conventional and hybrid motor vehicles, and other subsidiaries that produce specialized vehicles such as golf carts and all-terrain vehicles.
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.